Breaking News
Sort by:
Top Post
Novalis Biotech Invests in Ultra Sensitive Genomics Technology by Rarity Bioscience
Rarity Bioscience announces a new strategic investment from Belgium-based Novalis Biotech. The investment is facilitated […]
Nuevocor Closes US$24M Series A Financing to Advance Novel Gene Therapies for Cardiomyopathies
Nuevocor, a preclinical-stage biotech company specializing in gene therapy for cardiomyopathies, has announced the completion […]
Mnemo Therapeutics Announces €75 million Series A to Accelerate Next Generation Integrated CAR-T and Epigenetic Targeting Platform
Mnemo Therapeutics, a biotechnology company developing powerful cell therapies using a novel target identification engine, […]
Apollo Therapeutics Completes $145 Million Financing Led by Patient Square Capital to Expand and Advance Portfolio-Based Drug Development
Apollo Therapeutics, a portfolio-based biopharmaceutical company rapidly advancing potentially transformative treatments based on breakthrough discoveries, […]
BASMA.com Raises a $3M Series a Round to Scale Up Its Health Tech Platform in the MENA
BASMA.com is a digital healthcare platform working on redefining the orthodontics support experience with a […]
Synaptogenix Announces $12.5 Million Private Placement
Synaptogenix, Inc. (Nasdaq: SNPX), an emerging biopharmaceutical company focused on developing therapies for neurodegenerative diseases, today announced […]
Qure.ai ’s Brain CT AI Wins Funding from the NHS
The UK Department of Health and Social Care announced that Qure.ai has been selected as […]
Startup Hertility Health Raises £4.2M in Seed Funding to Help Reduce Diagnosis Time of Most Common Reproductive Issues
Hertility Health, the new women’s health start-up revolutionising the world of hormone and reproductive health, […]
TailorMed Fuels Further Growth with a $20 Million Financing, Led by Providence Ventures
TailorMed Medical Ltd., a leading patient financial navigation technology company that helps healthcare patients remove […]
Heartseed Raises $37 Million in Series C Funding to Accelerate Development of iPSC-derived Stem Cell Therapy for Heart Failure
Heartseed, a Tokyo-based biotechnology company developing iPSC-derived cardiomyocytes for heart failure (HF), today announced it […]
Medixine Raises €2.9M Funding to Help Healthcare Providers Offer Comprehensive Remote Care Services
The Finland-based telehealth provider Medixine has raised €2.9 million in funding led by a crowdfunding […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more